Versant Capital Management’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85K Hold
178
﹤0.01% 2567
2026
Q1
$2.12K Hold
178
﹤0.01% 2559
2025
Q4
$1.77K Sell
178
-1,509
-89% -$14.4K ﹤0.01% 2463
2025
Q3
$15.1K Buy
1,687
+1,509
+848% +$14K ﹤0.01% 1737
2025
Q2
$1.68K Sell
178
-1,309
-88% -$11.5K ﹤0.01% 2415
2025
Q1
$16.1K Buy
1,487
+1,047
+238% +$10.5K ﹤0.01% 1466
2024
Q4
$4.19K Sell
440
-216
-33% -$2.19K ﹤0.01% 1837
2024
Q3
$7.37K Sell
656
-45
-6% -$478 ﹤0.01% 1165
2024
Q2
$7.01K Buy
701
+134
+24% +$1.36K ﹤0.01% 1111
2024
Q1
$6.53K Buy
567
+435
+330% +$3.69K ﹤0.01% 928
2023
Q4
$962 Sell
132
-203
-61% -$1.6K ﹤0.01% 1524
2023
Q3
$3.05K Sell
335
-103
-24% -$1.24K ﹤0.01% 1156
2023
Q2
$5.33K Buy
438
+103
+31% +$1.15K ﹤0.01% 1017
2023
Q1
$4.32K Sell
335
-1,029
-75% -$18.9K ﹤0.01% 994
2022
Q4
$26.2K Sell
1,364
-1
-0.1% -$21 0.01% 372
2022
Q3
$26K Buy
+1,365
New +$28.1K 0.01% 355

Other funds holding AHCO

Versant Capital Management's AHCO Position: Q2 2026 in Review

Versant Capital Management held its AdaptHealth (AHCO) position steady in Q2 2026 at 178 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2567.

Versant Capital Management first reported a position in AHCO in Q3 2022 and has held it in 16 quarters since. The position peaked at $26.2K in Q4 2022. 17 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Versant Capital Management held 178 shares of AdaptHealth worth $1.85K as of Q2 2026.
  • Versant Capital Management left its AdaptHealth share count unchanged in Q2 2026.
  • AdaptHealth made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2567 holding.
  • Versant Capital Management first reported a position in AdaptHealth in Q3 2022 and has held it in 16 quarters since.
  • Versant Capital Management's AdaptHealth position peaked at $26.2K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.